Phyxiom, developer of a platform aiming to enhance asthma and COPD management, has announced its official launch.

DeepSight Technology announced today that it received FDA 510(k) clearance for its NeedleVue LC1 ultrasound system.

Lifecare today announced positive steps taken toward bringing a continuous glucose monitor (CGM) implant to the European ...

Vicarious Surgical (NYSE:RBOT) shared new details about clinical trial timelines for its surgical robot, leading to potential ...

Reprieve Cardiovascular announced today that it closed an oversubscribed Series B financing totaling $61 million.